1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hirugen in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (hirugen) | Trials (hirugen) | Recent Studies (post-2010) (hirugen) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 50 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maraganore, JM; McIntyre, TM; Prescott, SM; Seeger, AR; Zimmerman, GA | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hirugen
Article | Year |
---|---|
Hirudin-based peptides block the inflammatory effects of thrombin on endothelial cells.
Topics: Calcimycin; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Hirudins; Humans; Inflammation; Kinetics; Peptide Fragments; Platelet Activating Factor; Thrombin | 1990 |